Relapsing-remitting MS is the most common form, affecting about 85% of people initially diagnosed
Recent work, however, has also demonstrated that ghrelin levels rise through the night in lean men (481)
Even minor structural variations in peptide therapeutics can potentially impact efficacy, pharmacokinetics, immunogenicity, and long-term product stability, potentially leading to biosimilar comparability failure if not properly characterized
Patients frequently describe a profound, crushing fatigue that does not improve with rest, accompanied by a thick, disorienting cognitive impairment commonly referred to as "brain fog." For those living with these invisible illnesses, the frustration of navigating a medical system that often lacks clear answers can be just as exhausting as the physical symptoms themselves